(Q38133045)

29 August 2017

title

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. (English)

1 reference

29 August 2017

0 references

2

1 reference

29 August 2017

4

1 reference

29 August 2017

6

1 reference

29 August 2017

7

1 reference

29 August 2017

10

1 reference

29 August 2017

Harvey A Whiteford

1

0 references

Jürgen Rehm

series ordinal

3

object named as

Jürgen Rehm

1 reference

29 August 2017

Christopher J.L. Murray

series ordinal

12

object named as

Christopher J L Murray

1 reference

29 August 2017

13

Theo Vos

1 reference

29 August 2017

9

Abraham D Flaxman

1 reference

29 August 2017

5

Alize J Ferrari

1 reference

29 August 2017

8

Rosana E Norman

1 reference

29 August 2017

11

Roy Burstein

1 reference

29 August 2017

language of work or name

English

0 references

publication date

29 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

382

1 reference

29 August 2017

issue

9904

1 reference

29 August 2017

page(s)

1575-1586

1 reference

Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter?

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

The global burden of mental disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

The Lancet's series on global mental health: 1 year on.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

The global burden of disease, 1990–2020

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global Burden of Disease 2005: call for collaborators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global prevalence of anxiety disorders: a systematic review and meta-regression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Mortality among cocaine users: a systematic review of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

A systematic review of the global distribution and availability of prevalence data for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

A systematic review of the prevalence of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global epidemiology of mental disorders: what are we missing?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Epidemiology of psychiatric disability in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Is mental health in the Canadian population changing over time?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Resources for mental health: scarcity, inequity, and inefficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Global mental health: a failure of humanity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Cost of scaling up mental healthcare in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Treatment and prevention of mental disorders in low-income and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Packages of care for depression in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Mental health and psychosocial support in humanitarian settings: linking practice and research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Reducing the global burden of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Barriers to improvement of mental health services in low-income and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Scale up of services for mental health in low-income and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Grand challenges: Integrating mental health care into the non-communicable disease agenda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Suicide as an outcome for mental disorders. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Suicidal risk factors and completed suicide: meta-analyses based on psychological autopsy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

Cross-national difference in the prevalence of depression caused by the diagnostic threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961611-6

7 January 2021

10.1016/S0140-6736(13)61611-6

Identifiers

DOI

1 reference

29 August 2017

1 reference